Axa’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,001
Closed -$216K 1121
2025
Q1
$216K Sell
3,001
-132
-4% -$10.7K ﹤0.01% 1016
2024
Q4
$270K Sell
3,133
-6,344
-67% -$632K ﹤0.01% 1002
2024
Q3
$898K Sell
9,477
-7,281
-43% -$646K ﹤0.01% 891
2024
Q2
$1.6M Sell
16,758
-124,384
-88% -$14.8M ﹤0.01% 809
2024
Q1
$18.6M Sell
141,142
-33,649
-19% -$4.14M 0.06% 295
2023
Q4
$25.3M Sell
174,791
-27,684
-14% -$3.8M 0.08% 240
2023
Q3
$34.4M Buy
202,475
+87,055
+75% +$17.3M 0.12% 182
2023
Q2
$25.7M Buy
115,420
+4,044
+4% +$827K 0.09% 242
2023
Q1
$24.6M Sell
111,376
-45,124
-29% -$11.1M 0.08% 259
2022
Q4
$33.9M Buy
156,500
+91,381
+140% +$24.4M 0.12% 202
2022
Q3
$17.2M Buy
65,119
+45
+0.1% +$11.4K 0.07% 308
2022
Q2
$13.6M Buy
65,074
+2,622
+4% +$585K 0.05% 371
2022
Q1
$13.8M Sell
62,452
-4,023
-6% -$850K 0.04% 419
2021
Q4
$15.5M Buy
66,475
+2,154
+3% +$533K 0.04% 411
2021
Q3
$14.1M Buy
64,321
+17,669
+38% +$3.77M 0.04% 404
2021
Q2
$7.86M Buy
46,652
+8,120
+21% +$1.31M 0.02% 581
2021
Q1
$5.63M Buy
38,532
+14,414
+60% +$2.31M 0.02% 682
2020
Q4
$3.56M Sell
24,118
-18,640
-44% -$2.21M 0.01% 758
2020
Q3
$3.82M Sell
42,758
-198,069
-82% -$17.5M 0.01% 699
2020
Q2
$18.6M Buy
240,827
+163,374
+211% +$11.1M 0.07% 277
2020
Q1
$4.37M Sell
77,453
-81,527
-51% -$6.25M 0.02% 555
2019
Q4
$11.6M Sell
158,980
-273,900
-63% -$18.3M 0.05% 414
2019
Q3
$30.1M Buy
432,880
+75,264
+21% +$5.13M 0.12% 222
2019
Q2
$25.2M Buy
357,616
+348,873
+3,990% +$25.8M 0.1% 261
2019
Q1
$717K Buy
+8,743
New +$715K ﹤0.01% 1045
2018
Q2
Sell
-3,616
Closed -$335K 1343
2018
Q1
$335K Sell
3,616
-1,000
-22% -$110K ﹤0.01% 1236
2017
Q4
$590K Buy
4,616
+1,000
+28% +$136K ﹤0.01% 1123
2017
Q3
$493K Buy
3,616
+66
+2% +$7.85K ﹤0.01% 1108
2017
Q2
$374K Buy
3,550
+150
+4% +$16.3K ﹤0.01% 1105
2017
Q1
$359K Buy
+3,400
New +$331K ﹤0.01% 1129

Other funds holding ALB

Axa's ALB Position: Q2 2025 in Review

Axa sold out of Albemarle (ALB) in Q2 2025, closing a stake of 3,001 shares — an estimated $216K sold.

Axa first reported a position in ALB in Q1 2017 and held it in 30 quarters. The position peaked at $34.4M in Q3 2023. 698 funds tracked by Wall St. Rank hold ALB as of Q2 2025.

  • Axa reported no remaining Albemarle position as of Q2 2025 after selling out during the quarter.
  • Axa sold 3,001 Albemarle shares in Q2 2025, an estimated $216K.
  • Axa first reported a position in Albemarle in Q1 2017 and held it in 30 quarters.
  • Axa's Albemarle position peaked at $34.4M in Q3 2023.
  • 698 funds tracked by Wall St. Rank held Albemarle as of Q2 2025.

Based on Axa's 13F filing for Q2 2025, filed 14 Aug 2025.